Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials
Authors
Keywords
-
Journal
EPILEPSIA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-05-26
DOI
10.1111/epi.16542
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
- (2020) Ian Miller et al. JAMA Neurology
- Cannabidiol efficacy and clobazam status: A systematic review and meta‐analysis
- (2020) Simona Lattanzi et al. EPILEPSIA
- Parasitic pharmacology: A plausible mechanism of action for cannabidiol
- (2019) Geert Jan Groeneveld et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
- (2019) Valentina Franco et al. DRUGS
- Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam
- (2019) Michael A. Rogawski EPILEPSY & BEHAVIOR
- Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program
- (2019) Tyler E. Gaston et al. EPILEPSY & BEHAVIOR
- Drug–drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures
- (2019) Pavel Klein et al. EPILEPSY & BEHAVIOR
- Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
- (2019) Lyndsey L. Anderson et al. EPILEPSIA
- A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?
- (2019) J. Helen Cross et al. NEUROPHARMACOLOGY
- Clinical trial simulations of the interaction between cannabidiol and clobazam and effect on drop‐seizure frequency
- (2019) Kirsten Riber Bergmann et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam
- (2019) Taylor E. Savage et al. EPILEPSY RESEARCH
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- (2016) Evan J. Hess et al. EPILEPSIA
- Cannabidiol in patients with treatment-resistant epilepsy
- (2016) David E Mandelbaum LANCET NEUROLOGY
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Clobazam and Its Active Metabolite N-desmethylclobazam Display Significantly Greater Affinities for α2- versus α1-GABAA–Receptor Complexes
- (2014) Henrik Sindal Jensen et al. PLoS One
- Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
- (2013) Rongrong Jiang et al. Drug Metabolism and Pharmacokinetics
- Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
- (2013) Stephen M. Stout et al. DRUG METABOLISM REVIEWS
- Clobazam Therapeutic Drug Monitoring
- (2013) Jose de Leon et al. THERAPEUTIC DRUG MONITORING
- Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
- (2011) Satoshi Yamaori et al. LIFE SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started